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Precursor mRNA splicing is one of the most highly regulated processes in metazoan species. In
addition to generating vast repertoires of RNAs and proteins, splicing has a profound impact on
other gene regulatory layers, including mRNA transcription, turnover, transport, and translation.
Conversely, factors regulating chromatin and transcription complexes impact the splicing process.
This extensive crosstalk between gene regulatory layers takes advantage of dynamic spatial,
physical, and temporal organizational properties of the cell nucleus, and further emphasizes the
importance of developing a multidimensional understanding of splicing control.Introduction
The splicing of messenger RNA precursors (pre-mRNA) to
mature mRNAs is a highly dynamic and flexible process that
impacts almost every aspect of eukaryotic cell biology. The
formation of active splicing complexes—or ‘‘spliceosomes’’—
occurs via step-wise assembly pathways on pre-mRNAs. Small
nuclear ribonucleoprotein particles (snRNPs): U1, U2, U4/U6,
and U5, in the case of the major spliceosome, and U11, U12,
U4atac/U6atac, and U5, in the case of the minor spliceosome,
together with an additional 150 proteins, associate with pre-
mRNAs, initially through direct recognition of short sequences
at the exon/intron boundaries. Key features of spliceosome
formation are shown in Figure 1 and have been reviewed in detail
elsewhere (Hoskins and Moore, 2012; Wahl et al., 2009).
Spliceosome assembly can be regulated in extraordinarily
diverse ways, particularly in metazoans. The major steps involve
formation of the commitment complex followed by the pre-
splicing complex and culminating with assembly of the active
spliceosome. These steps appear to be reversible and potential
points of regulation (Hoskins et al., 2011), and accumulating
evidence indicates that formation of the commitment and pre-
splicing complexes may be the most often subject to control
(Chen and Manley, 2009).
Analysis of human genome architecture emphasizes a major
challenge for accurate recognition and regulation of splice sites
by the splicing machinery, namely that exons represent only 3%
of the human genome (ENCODE Project Consortium, 2012).
Accumulating evidence indicates that the high-fidelity process
of splice site selection is not simply governed by the interaction
of snRNPs and non-snRNP protein factors with pre-mRNA but
that factors associated with chromatin and the transcriptional
machinery are also important (Luco et al., 2011). Moreover,
splicing can ‘‘reach back’’ to impact chromatin composition1252 Cell 152, March 14, 2013 ª2013 Elsevier Inc.and transcriptional activity, as well as influence parallel or
downstream steps in gene expression including 30-end pro-
cessing, mRNA turnover, and translation (de Almeida and
Carmo-Fonseca, 2012; Moore and Proudfoot, 2009). Therefore,
understanding fundamental biological processes such as cell
differentiation and development, as well as disease mecha-
nisms, will require knowledge of the crosstalk between splicing
and other regulatory layers in cells. A major facet of developing
such knowledge is to understand how splicing is physically,
spatially, and temporally integrated with other gene expression
processes in the cell nucleus. This review focuses on these
topics, with an emphasis on knowledge that has been gained
from the application of genome-wide strategies, together with
focusedmolecular, biochemical, and cell biological approaches.
Regulation of Splicing at the Level of RNA
Regulatory RNA Sequences
Alternative splicing (AS) is the process by which different pairs of
splice sites are selected in a pre-mRNA transcript to produce
distinct mRNA and protein isoforms. The importance of under-
standing AS regulation is underscored by its widespread nature
and its numerous defined roles in critical biological processes
including cell growth, cell death, pluripotency, cell differentia-
tion, development, circadian rhythms, responses to environ-
mental challenge, pathogen exposure, and disease (Irimia and
Blencowe, 2012; Kalsotra and Cooper, 2011). Analysis of data
from high-throughput RNA sequencing (RNA-Seq) of organ tran-
scriptomes has indicated that at least 95% of human multi-exon
genes produce alternatively spliced transcripts (Pan et al., 2008;
Wang et al., 2008) and that the frequency of AS scales with cell
type and species complexity (Barbosa-Morais et al., 2012;
Nilsen and Graveley, 2010). The main types of AS found in
eukaryotes are ‘‘cassette’’ exon skipping, alternative 50 and 30
Figure 1. Cotranscriptional and Posttranscriptional Aspects of Pre-mRNA Splicing
Cotranscriptional spliceosome assembly initiates with the binding of U1 snRNP to the 50 splice site, which is enhanced by exon-bound SR proteins and, for the
first exon, the cap binding complex (CBC). A cross-intron commitment complex is formed upon association of U2 snRNP auxiliary factor (U2AF) with the 30 splice
site and adjacent intronic polypyrimidine tract, and branch point binding protein (BBP/SF1) with the branch site. Bridging interactions between these factors
across internal exons, or ‘‘exon definition,’’ occurs within the commitment complex. Transition from a commitment complex to a presplicing complex entails
communication between 50 and 30 splice sites, and the addition of U2 snRNP to the branch site along with numerous additional proteins (not shown). Subsequent
association of U4/U6/U5 tri-snRNP, together with still more protein factors, and dynamic remodeling of RNA-protein, protein-protein, and RNA-RNA interactions,
ultimately leads to formation of the catalytically active spliceosome. The two trans-esterification steps of splicing yield the excised intron in the form of the
characteristic branched ‘‘lariat’’ structure and the ligated exons that formmaturemRNA. The assembly of most splicing factors and splicing of constitutive introns
is thought to occur cotranscriptionally, whereas splicing of regulated alternative introns often occurs posttranscriptionally. In the example shown, exon 4 is
a regulated alternative exon controlled by an hnRNP protein, which prevents the splicing factors bound to flanking splice sites from engaging in productive
interactions and therefore promotes exon skipping. At terminal exons (exon 5), interactions between the splicing factors bound to the upstream 30 splice site and
the exon interact with components of the cleavage and polyadenlyationmachinery (CPSF andCstF are shown; see also Figure 4A). The association of the splicing
factors with the pre-mRNA is enhanced throughout the transcription process by interactions with the C-terminal domain of RNA polymerase II. The EJC is
recruited upstream of splice junctions upon splicing. The EJC and SR proteins mutually stabilize one another to generate the mature mRNP, which is then
exported to the cytoplasm.splice site selection, alternative retained introns, and mutually
exclusive exons. The vast majority of AS events have not been
functionally characterized on any level, and this represents
a major challenge for biological research. However, large-scale
studies of splice variants employing a mix of computational
and experimental approaches have provided evidence for
widespread roles of regulated alternative exons in the control
of protein interaction networks, and in cell signaling (Buljan
et al., 2012; Ellis et al., 2012; Weatheritt and Gibson, 2012).
The selection of correct pairs of 50 and 30 splice sites in
pre-mRNA is governed in part by cis-acting RNA sequences
that collectively comprise the ‘‘splicing code’’ (Wang and Burge,
2008). The code utilizes a surprisingly minimal set of highly
conserved features; these are the intronic dinucleotides GU
and AG (with variations used by the minor spliceosome) at the
50 and 30 splice sites, respectively, and the intronic adenosine
residue that forms the branched lariat structure. Additional
nucleotides surrounding these positions display sequence
preferences that reflect requirements for base-pairing interac-tions with the snRNA components of snRNPs during spliceo-
some formation (Wahl et al., 2009). Although these minimal
core elements delineate sites of splicing, they lack sufficient
information to discriminate correct from incorrect splice sites
and to regulate AS.
Combinations of additional sequence elements referred to
as exonic/intronic splicing enhancers (E/ISEs) and silencers
(E/ISSs) serve to promote and repress splice site selection.
They operate in the context of achieving fidelity and in the regu-
lation of this process (Wang andBurge, 2008). Themajority of the
code elements comprise short and degenerate linear motifs,
although interesting examples of structured RNA elements
have been discovered that function in splice site selection
(Graveley, 2005; McManus and Graveley, 2011). The major
contribution of linear motifs to splicing regulation is reflected
by the ability of increasingly sophisticated computer algorithms
to predict splicing outcomes from genomic sequence alone
(Barash et al., 2010; Zhang et al., 2010). The emerging picture,
supported by site-directed mutagenesis of cis elements, is thatCell 152, March 14, 2013 ª2013 Elsevier Inc. 1253
splice site selection involves the concerted action of multiple
enhancer and silencer elements that are concentrated in regions
proximal (typically within 300 nts) to splice sites (Barash et al.,
2010). In particular, enhancers that support constitutive exon
splicing are typically concentrated in exons, whereas enhancers
and silencers that function in the regulation of AS can be located
in alternative exons, although they are most often concentrated
in the immediate flanking intronic regions (Barash et al., 2010).
Additionally, silencer elements are enriched in sequences
surrounding cryptic splice sites—sequences that resemble
splice sites but are not functional splice sites (Wang and Burge,
2008).
Regulatory Proteins
Two major classes of widely expressed trans-acting factors that
control splice site recognition are the SR proteins and heteroge-
neous ribonucleoproteins (hnRNPs) (Long and Caceres, 2009;
Martinez-Contreras et al., 2007). Depending on their binding
location and the surrounding sequence context, members
of each class can promote or repress splice site selection
through associating with enhancers or silencers, respectively.
For example, members of the SR family of proteins contain
one or two RNA recognition motifs that bind ESEs and are
thought to promote splicing by facilitating exon-spanning inter-
actions that occur between splice sites (referred to as ‘‘exon
definition’’) and also by forging interactions with core spliceo-
somal proteins (Figure 1). In addition to widely expressed
trans-acting factors, several tissue-specific RNA-binding
splicing regulators have been characterized (Irimia and Blen-
cowe, 2012; Licatalosi and Darnell, 2010). These include
the neural-specific factors Nova, PTBP2/nPTB/brPTB, and
nSR100/SRRM4, and factors such as RBFOX, MBNL, CELF,
TIA, and STAR family proteins that are differentially expressed
between a variety of cell and tissue types. Through the use of
splicing-sensitive microarrays and RNA-Seq to detect exons
affected by the knockout or knockdown of these factors, in
combination with splicing code predictions and in vivo cross-
linking coupled to immunoprecipitation and sequencing (HITS-
CLIP or CLIP-Seq), ‘‘maps’’ of several of these proteins have
been generated that correlate their binding location (i.e., within
alternative exons and/or the flanking introns) with functions in
promoting exon inclusion or skipping (Licatalosi and Darnell,
2010; Witten and Ule, 2011). As mentioned earlier, where
studied, these proteins appear to act primarily at the earliest
stages of spliceosome formation to control splice site selection.
Integration of Splicingwith Chromatin and Transcription
Despite major progress in the characterization of factors that
control splicing at the level of RNA, the impact of linked steps in
gene regulation and of nuclear organization on the splicing
process is less well understood. The fact that synthetic
pre-mRNAs can be efficiently spliced in nuclear extracts
demonstrates that splicing can be uncoupled from other nuclear
processes in vitro. However, mounting evidence indicates that
splicing, transcription, and chromatin modification are highly
integrated in the cell. Thus, key to understanding the role of chro-
matin and transcription in the control of splicing is knowingwhich
aspectsof the splicingprocessoccurco- or posttranscriptionally.
Some of the first mechanistic insights into the cotranscrip-
tional nature of splicing came from chromatin immunoprecipita-1254 Cell 152, March 14, 2013 ª2013 Elsevier Inc.tion studies in yeast. These experiments revealed that splicing
factors fail to associate with intronless genes but are recruited
to intron-containing genes concomitant with the transcription
of the splice sites they recognize (Go¨rnemann et al., 2005;
Lacadie and Rosbash, 2005). The main exceptions were genes
containing short last exons, in which case U1 snRNP was
recruited cotranscriptionally, but U2 snRNP was recruited post-
transcriptionally (Tardiff et al., 2006). Similar approaches have
been used in human cells with similar results (Listerman et al.,
2006). These data paint a general picture in which the splicing
machinery is typically recruited to pre-mRNA in a cotranscrip-
tional manner.
Although splicing factors are cotranscriptionally recruited, it
does not necessarily follow that the splicing reaction itself
occurs cotranscriptionally. Recently, Vargas et al. used in situ
hybridization methods with single-molecule resolution and
found that constitutively spliced introns, which typically are
efficiently spliced, were removed cotranscriptionally (Vargas
et al., 2011). However, mutations that decreased the splicing
efficiency, for instance by sequestering splicing signals in
RNA secondary structures, caused introns to be posttranscrip-
tionally spliced. More interestingly, two alternatively spliced
introns examined were found to be posttranscriptionally
spliced. This study suggested that introns could be either co-
transcriptionally or posttranscriptionally spliced, in part de-
pending on the strength and type of surrounding cis-regulatory
elements.
The extent to which specific classes of splicing events occur
co- or posttranscriptionally has since been examined on a
genome-wide level. Several groups have analyzed RNA-Seq
data generated from total cellular RNA, total nuclear RNA, nucle-
oplasmic RNA, or chromatin-associated RNA (Ameur et al.,
2011; Bhatt et al., 2012; Khodor et al., 2012; Khodor et al.,
2011; Tilgner et al., 2012). Each group used a different method
to assess the extent of cotranscriptional splicing. Though the
precise frequency differed in each study, most introns appeared
to be cotranscriptionally spliced. The likelihood of cotranscrip-
tional splicing increases with increased distance of introns
from the 30 ends of genes (Khodor et al., 2012). Strikingly, the
set of posttranscriptionally spliced introns is strongly enriched
for alternatively spliced introns. Moreover, it was observed that
most human transcripts are cleaved and polyadenylated before
splicing of all introns is complete, yet these transcripts remain
associated with the chromatin until splicing is finished (Bhatt
et al., 2012).
Because most splicing events (constitutive and alternative)
occur cotranscriptionally, an important goal is to determine the
extent to which chromatin and transcription factors impact
them. Understanding such links necessitates considering the
possible contribution of each step in transcription, through
initiation, elongation, and termination, and therefore also how
transcription is impacted by different chromatin states.
Promoter-Directed Control of Splicing
Pioneering studies performed in the late 90’s employing trans-
fected minigene reporter experiments demonstrated that the
type of promoter used to drive transcription by RNA poly-
merase II (Pol II) can impact the level of AS of a downstream
exon (Cramer et al., 1997). Two nonexclusive models were
proposed to explain this effect (Figure 2). In the ‘‘recruitment
model,’’ a change in promoter architecture results in the recruit-
ment of one or more splicing factors to the transcription
machinery that in turn impact splicing of the nascent RNA. In
the ‘‘kinetic model,’’ the change in promoter architecture affects
the elongation rate of Pol II, such that there is more or less time
for splice sites or other splicing signals flanking the alternative
exon to be recognized by trans-acting factors (Kornblihtt,
2007). For example, if these splice sites are weak (i.e., they
deviate from consensus splice site sequences associated with
efficient recognition by the splicing machinery), rapid elongation
will expose distal, stronger splice sites such that exon skipping
occurs, as productive splicing complexes will associate with
the stronger splice sites first. If elongation is slow, there is
increased time for splicing factors to bind to the weak sites in
the nascent RNA and promote exon inclusion. Alternatively,
reduced Pol II elongation kinetics can also favor the recognition
of splicing silencer elements surrounding an alternative exon,
resulting in increased exon skipping.
Although the mechanistic basis of promoter-dependent
effects on AS has been investigated using model splicing
reporters (see below), it is unclear to what extent and under
what conditions natural switching of promoters may function in
the regulation of downstream AS events in vivo. The analysis
of large collections of full-length transcript sequences has
revealed weak correlations between the use of alternative tran-
script start sites and the splicing of downstream cassette exons
(Chern et al., 2008), although it was not determinedwhether such
correlations may reflect tissue-dependent effects that indepen-
dently result in the increased complexity of transcription start
site usage, and the increased complexity of AS. With the accu-
mulation of data sets from the modENCODE/ENCODE projects
and other studies that have yielded parallel genome-
wide surveys of multiple aspects of gene regulation, including
transcription factor occupancy, epigenetic modifications, long-
range chromatin interactions and transcriptome profiles, it
should in principle be possible to obtain higher resolution pre-
dictions of causative promoter-dependent effects on splicing
and other RNA processing steps.
Despite our incomplete understanding of promoter-depen-
dent effects on RNA processing in vivo, evidence from numerous
model systems indicates that the strength and composition
of a promoter can impact splicing outcomes. For example, the
recruitment of the multifunctional proteins PSF/p54nrb by
promoter-bound activators stimulates splicing of first introns
(Rosonina et al., 2005). Activation of hormone receptors by
cognate ligands has been linked to specific splicing outcomes
(Auboeuf et al., 2002), and the association of PGC-1, a transcrip-
tional coactivator that plays a major role in the regulation of
adaptive thermogenesis, alters splicing activity when it is bound
to a gene (Monsalve et al., 2000). Interestingly, PGC-1 contains
an RS domain that may function to recruit splicing factors to
PGC-1-activated promoters. In the above and additional ex-
amples, the type of promoter-bound activator may influence
splicing outcomes, in part by altering the composition and/or
the processivity of Pol II (David and Manley, 2011). Under-
standing such effects therefore entails knowledge of factors
that bridge activators and Pol II, and of components of Pol IIthat in turn transmit information to the nascent RNA to impact
splicing.
A recent study suggests that the Mediator complex may be
involved in integrating and relaying information to direct splicing
decisions (Huang et al., 2012). Mediator is a large multisubunit
complex that functions as a general factor at the interface
between promoter-bound transcriptional activators and Pol II
(Malik and Roeder, 2010). In addition to its general role,
locus-specific functions have been ascribed to Mediator, where
changes in its composition can lead to differential outcomes
in transcription, and possibly RNA processing. Huang and
colleagues showed that the MED23 subunit of Mediator physi-
cally interacts with several splicing and polyadenylation factors,
most notably hnRNP L (Huang et al., 2012). Indeed, MED23
was required for regulating the AS of a subset of hnRNP
L targets. It will be of interest to determine how and to what
extent Mediator relays information to impact the splicing
machinery on hnRNP L-regulated targets, and whether it acts
similarly to regulate RNA processing through other RNA-
binding proteins.
The RNA Polymerase II CTD in Splicing Control
The C-terminal domain (CTD) of Pol II’s largest subunit impacts
different stages of mRNA biogenesis, including addition of
a protective cap structure on the 50-end, splicing and formation
of the mature 30-end. The CTD consists of a repeating heptad
amino acid sequence with the consensus Y1S2P3T4S5P6S7,
and is predicted to be unstructured in isolation of other factors
(Hsin and Manley, 2012). The CTD can be posttranslationally
modified by phosphorylation on each of the residues
Y1S2T4S5S7, and these changes play important and distinct roles
in transcription and RNA processing (Hsin and Manley, 2012).
Initial evidence for a role of the CTD in RNA processing came
from experiments employing expression of an alpha-amanitin
resistant mutant of Pol II that harbors a truncated CTD. Trunca-
tion to five repeats led to defects in capping, splicing, and 30-end
processing of model pre-mRNA reporters (McCracken et al.,
1997b; McCracken et al., 1997a), and the CTD was later found
to affect AS outcomes (de la Mata and Kornblihtt, 2006;
Rosonina and Blencowe, 2004). The CTD promotes capping
and 30-end formation through direct interactions with sets of
factors dedicated to these processes, and increasing evidence
indicates that it also serves as a platform to recruit splicing
factors that may participate in commitment complex formation
and the regulation of AS (David and Manley, 2011; Hsin and
Manley, 2012).
Affinity chromatography identified splicing and dual splicing/
transcription-associated factors as CTD-binding proteins.
These include yeast Prp40, human TCERG1/CA150, p54nrb/
PSF proteins, SR proteins, and U2AF (Hsin and Manley, 2012).
Recent work supports an RNA-dependent interaction of U2AF
with the phosphorylated CTD to stimulate splicing in vitro
through an association with the core spliceosomal factor
PRP19C (David et al., 2011). Taken together with previous
work showing that a phosphorylated CTD polypeptide can stim-
ulate splicing in vitro (Hirose et al., 1999) and that the CTD is
more active in promoting splicing of a substrate that has the
capacity to form exon-definition interactions compared to
a substrate that cannot (Zeng and Berget, 2000), it is interestingCell 152, March 14, 2013 ª2013 Elsevier Inc. 1255
Figure 2. Models for Chromatin and Transcription Elongation-Mediated Modulation of Alternative Splicing
(Top Left) Promoter recruitment model. Different promoters differentially recruit splicing factors to the transcription complex. At promoters which fail to recruit
a key splicing factor (shown as an SR protein), the regulated alternative exon (exon 2) will be skipped, whereas genes containing promoters that recruit the splicing
factor will include exon 2.
(Top Right) Promoter-directed kinetic model. Different promoters assemble transcription complexes capable of different transcription elongation rates. At
promoters that assemble fast transcription elongation complexes, the regulated alternative exon (exon 2) will be skipped, whereas genes containing promoters
that assemble slow elongation complexes will include exon 2. This model requires that the alternative exon contains weak 30 and/or 50 splice sites in order to be
skipped when the gene is rapidly transcribed.
(Bottom Left) Chromatin-mediated recruitment model. The splicing of an alternative exon can be regulated by the chromatin-mediated recruitment of a splicing
repressor. In cells that skip the exon, an adaptor protein associates with the nucleosome assembled at the alternative exon, which in turn recruits a splicing
repressor. In cells that include the alternative exon, the adaptor protein and/or repressor are not expressed, or the nucleosome at the regulated alternative exon is
(legend continued on next page)
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to consider that the CTDmight function as a platform to facilitate
exon definition and commitment complex formation (Figures 1
and 2). In this manner, the CTD may also serve to tether exons
separated by great intronic distances to promote cotranscrip-
tional splicing (Dye et al., 2006). It will be important to determine
whether the CTD plays such roles in vivo in future work.
RNA Polymerase II Elongation and the Control
of Alternative Splicing
Numerous studies employing model experimental systems
designed to alter the rate of Pol II elongation have provided
evidence supporting the aforementioned kinetic model (Korn-
blihtt, 2007; Luco et al., 2011). More recent work has applied
genome-wide approaches to understand the extent and func-
tional relevance of this mode of regulation. In one study,
UV-induced DNA damage was found to result in a hyperphos-
phorylated form of the CTD and reduced Pol II elongation
kinetics, and these changes were proposed to cause changes
in AS of genes that function in cell cycle control and apoptosis
(Mun˜oz et al., 2009). Another study globally monitored AS
changes following treatment of cells with camptothecin and
5,6-dichloro-1-b-D-ribofuranosyl-benzimidazole (DRB), which
act through different mechanisms to inhibit Pol II elongation
(Ip et al., 2011). Concentrations of these drugs that partially
inhibit Pol II elongation preferentially affected AS and transcript
levels of genes encoding RNA splicing factors and other RNA-
binding protein (RBP) genes. Many of the induced AS changes
introduced premature termination codons (PTCs) that elicited
nonsense-mediated mRNA decay (NMD; see below), which
further contributed to reductions in transcript levels. These
results suggest that conditions globally impacting elongation
rates can lead to the AS-mediated downregulation of RNA
processing factors, such that the levels of these factors are
calibrated with the overall RNA processing ‘‘needs’’ of the cell.
This type of Pol II-coupled AS network appears to be highly
conserved, because amino acid starvation, which causes
reduced elongation and/or increased Pol II pausing, was also
found to affect the AS of transcripts from splicing factor genes,
including several that can elicit NMD, in C. elegans (Ip et al.,
2011).
Chromatin Structure Distinguishes Exons from Introns
Although recognition of splice sites fundamentally has to occur
through direct interactions with pre-mRNA, chromatin features
can shape decisions about splice site usage and exon selection.
The basic unit of chromatin structure is the nucleosome, which
comprises 147 base-pairs of DNA wrapped around a histone
octamer consisting of two copies each of histones H2A, H2B,
H3, and H4 (Luger et al., 1997). Chromatin function can be regu-
lated by substituting canonical histones with nonallelic variants
and through posttranslational modification of histone tail resi-
dues most notably by methylation and acetylation (Kouzarides,
2007; Talbert and Henikoff, 2010). These histone ‘‘marks’’ and
direct modifications of DNA, including the addition ofnot modified and therefore cannot recruit the repressor. Similar to this model, a n
activator, as proposed for Psip1/Ledgf (Pradeepa et al., 2012).
(Bottom Right) Chromatin-mediated kinetic model. The splicing of an alternative
scription elongation. Unmodified nucleosomes can be transcribed rapidly, resulti
assembled on exon 2 has an H3K9me3 mark, CBX3 interacts with the modified n
splicing of the regulated alternative exon.5-methylcytosine, 5-hydroxymethylcytosine, and other deriva-
tives (Wu and Zhang, 2011), affect the functional state of chro-
matin by altering its compaction and by modulating the binding
of effector proteins. It is well established that these features
have nonuniform distribution along genes with unique signatures
marking promoters and gene bodies in a transcription-depen-
dent manner (Smolle and Workman, 2013). More recently, it
has become apparent that these chromatin features are also
differentially distributed with respect to exon-intron boundaries,
and that this differential marking participates in exon recognition.
Analysis of data sets from chromatin immunoprecipitation
high-throughput sequencing (ChIP-seq), and from micrococcal
nuclease digestion followed by sequencing revealed that nucle-
osomes in a range of organisms display increased occupancy
over exons relative to neighboring intronic sequence (Andersson
et al., 2009; Chodavarapu et al., 2010; Schwartz et al., 2009;
Spies et al., 2009; Tilgner et al., 2009; Wilhelm et al., 2011). Sug-
gesting a possible role in facilitating splicing, exons that have
weak splice sites and that are surrounded by relatively long
introns have greater levels of nucleosome occupancy than do
exons with strong splice sites or that are flanked by short introns
(Spies et al., 2009; Tilgner et al., 2009). To assess whether exon-
enriched nucleosomes might be compositionally—and therefore
functionally—distinct, a number of studies examined global
distributions of specific histone modifications with respect to
exon-intron boundaries (Andersson et al., 2009; Dhami et al.,
2010; Hon et al., 2009; Huff et al., 2010; Kolasinska-Zwierz
et al., 2009; Schwartz et al., 2009; Spies et al., 2009). Some of
these studies reached different conclusions as to which modifi-
cations show enrichment over exons and to what extent such
enrichment is a consequence of increased nucleosome occu-
pancy. Nevertheless, trimethylation of lysine 36 on histone H3
(H3K36me3) was shown in multiple studies to be enriched over
exons above background nucleosome levels (Andersson et al.,
2009; Huff et al., 2010; Spies et al., 2009). Exon-enriched nucle-
osomes may also differ in their histone variant composition. The
H2A variant, H2A.Bbd, which is associated with active, intron-
containing genes, is enriched in positioned nucleosomes
flanking both 50 and 30splice sites (Tolstorukov et al., 2012).
Such specific histone marks or variants could therefore play
a widespread role in splicing (see below).
Base pair composition affects physical properties of the DNA
and is not uniform across the genome. Exons are in general
associated with higher GC content, which is an important feature
governing nucleosome occupancy (Tillo and Hughes, 2009). A
recent study found differences in relative GC content between
exons and introns that may have evolved to contribute to splicing
(Amit et al., 2012). In a reconstructed ‘‘ancestral’’ state, genes
contained exons with a low GC content that were flanked by
short introns of an even lower GC content. These subsequently
diverged to yield two different types of gene architectures in
animal species. In one architectural state, genes retained lowucleosome-associated adaptor protein may also function to recruit a splicing
exon can be regulated by a chromatin-mediated change in the rate of tran-
ng in skipping of the regulated alternative exon. In cells where the nucleosome
ucleosome, slows down the transcription elongation complex, and enhances
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exonic GC content with lower GC content in introns but experi-
enced an increase in intron length. In the other state, genes
retained short intron length but saw an overall increase in GC
content that eliminated differential exon-intron composition
(Amit et al., 2012). Bioinformatic and experimental evidence
supports a role for differential GC content in promoting exon
recognition in the context of the first type of architecture (Amit
et al., 2012). However, to what extent differential GC content
between exons and introns influences exon recognition through
possible mechanisms associated with (modified) nucleosome
deposition is unclear.
Studies employing genome-wide bisulphite sequencing have
suggested a role for modified cytosines at exonic CpG dinucle-
otides in exon recognition and the regulation of AS. Modified
CpG dinucleotides are enriched within exons relative to introns
in both plants and animals (Chodavarapu et al., 2010; Feng
et al., 2010; Laurent et al., 2010) with characteristic patterns at
the 50 and 30 splice sites (Laurent et al., 2010). Moreover,
widespread differences in CpG methylation have been detected
betweenworker and queen bee genomes, and intriguingly, some
of these differential methylation patterns appear to correlate with
differential AS (Lyko et al., 2010). Highlighting a possible role of
DNA epigenetic marks in mediating tissue-specific differences,
in mammalian neuronal tissues hydroxymethylation rather than
methylation was found to have significant exonic enrichment
(Khare et al., 2012). The possible mechanisms by which such
modifications affect splicing await future work.
Chromatin-Dependent Recruitment of the Splicing
Machinery
Analogous to roles of promoter architecture and the Pol II
CTD, accumulating evidence suggests that chromatin structure
throughout a gene facilitates splicing factor recruitment to
nascent transcripts. It has been proposed that splicing factors
interact with chromatin directly, or indirectly through inter-
mediate ‘‘adaptor’’ proteins (Figure 2). H3K4me3, which marks
the promoters of actively-transcribed genes, binds specifically
to CHD1, a protein that associates with U2 snRNP. Indeed,
this interaction was shown to increase splicing efficiency (Sims
et al., 2007). Similarly, H3K36me3, which is enriched over exons,
was recently reported to interact with a short splice iso-
form of Psip1/Ledgf, which in turn associates with several
splicing factors including the SR protein SRSF1 (Pradeepa
et al., 2012). Supporting a possible role as a recruitment adaptor,
knockdown of Psip1 led to a change in SRSF1 localization and
affected AS.
The aforementioned H2A.Bbd histone variant appears to func-
tion in splicing through the recruitment of splicing components
(Tolstorukov et al., 2012). Mass spectrometry data revealed
that H2A.Bbd interacts with numerous components of the
spliceosome, and depletion of this histone variant led to the
widespread disruption of constitutive and alternative splicing.
Another recent study suggests that recruitment of splicing
components by chromatin may be effected through global
changes in histone hyperacetylation or changes in the levels of
the heterochromatin-associated protein HP1a (Schor et al.,
2012). These alterations result in the global redistribution of
numerous splicing factors from chromatin to nuclear speckle
domains, which are thought to predominantly represent sites1258 Cell 152, March 14, 2013 ª2013 Elsevier Inc.of splicing factor storage (Schor et al., 2012) (see below). Collec-
tively, these studies point to characteristic patterns of chromatin
structure associated with active gene expression that may
have a widespread impact on the nuclear localization of the
splicing machinery, which in turn can impact splicing of nascent
transcripts.
Chromatin structure can be altered in highly specific ways
within genes, for example, in response to environmental and
developmental cues. Such ‘‘local’’ changes are thought to also
impact AS of proximal exons on nascent RNA through the action
of adaptor proteins that bridge chromatin marks and splicing
factors. The first example of this type of proposed mechanism
involves the mutually exclusive exons IIIb and IIIc in the FGFR2
gene. Switching from exon IIIb to exon IIIc alters the ligand
affinity of this receptor and represents an important step in
the epithelial to mesenchymal transition. In mesenchymal cells,
the region encompassing these exons is characterized by
elevated levels of H3K36me3 and low levels of H3K4me3 and
H3K27me3 (Luco et al., 2010). H3K36me3 modifications favor
the binding of MRG15, which promotes the recruitment of the
splicing regulator PTBP1 to nascent RNA, and as a consequence
represses the use of exon IIIb in these cells (Luco et al., 2010).
Consistent with a more widespread role for an MRG15-adaptor
mechanism to control AS, significantly overlapping subsets
of cassette exons were affected by individual knockdown of
MRG15 and PTBP1 (Luco et al., 2010). However, the affected
exons generally displayed modest changes in inclusion level
and were found to be surrounded by relatively weak PTBP1-
binding sites, suggesting that this adaptor mechanism may be
more important for augmenting or stabilizing patterns of AS
achieved by direct action of RNA-based regulators, rather than
acting to promote pronounced cell-type-dependent, switch-
like regulation of AS.
Chromatin Structure Affects Splicing by Influencing Pol
II Elongation
Specific features of chromatin structure, as well as chromatin-
associated regulators, can influence splice site choice by
impacting transcription elongation (Figure 2). SWI/SNF chro-
matin remodelling factors interact directly with Pol II (Neish
et al., 1998; Wilson et al., 1996), and with splicing factors
(Batsche´ et al., 2006), suggesting that these factorsmight impact
splicing in an elongation-dependent manner. Supporting this
view, the association of the ATP-dependent SWI/SNF-type
chromatin remodelling factor BRM with the human CD44 gene
coincides with a change in inclusion levels of alternative exons
in CD44 transcripts (Batsche´ et al., 2006). Increased occupancy
of Pol II with elevated S5 phosphorylation of the CTD (which is
associatedwith a paused form of Pol II) was detected specifically
over CD44 alternative exons, indicating that a reduced elonga-
tion rate or increased pausing of Pol II might be responsible for
the change in AS. The BRM ATPase activity required for chro-
matin remodeling was, however, not required for the change in
AS (Batsche´ et al., 2006).
Recent studies analyzing BRM in Drosophila suggest that
it acts together with other members of the SWI/SNF com-
plex to regulate AS and polyadenylation in a locus-specific
manner (Waldholm et al., 2011; Zraly and Dingwall, 2012). Devel-
opmentally regulated intron retention of the Eig71Eh pre-mRNA
Figure 3. Reverse-Coupling Mechanisms
(A) Splicing enhances transcription-associated histone modification. Splicing
of the first intron enhances transcription initiation and stabilizes promoter-
associated marks, including H3K4me3 and H3K9ac, near the 50 splice site of
exon 1. Splicing may also facilitate a transition between the elongation-
associated marks H3K79me2 and H3K36me3 at the 30 splice site of the first
intron. Internal exons are particularly enriched for H3K36me3-modified
nucleosomes, due in part to splicing-increased nucleosome occupancy and
action of the histone methyltransferase SETD2 associated with elongating
Pol II. These marks may also serve to reinforce splicing patterns of nascent
pre-mRNA.
(B) The SR protein SRSF2/SC35, which regulates splicing of alternative exons,
also enhances transcription elongation by recruiting P-TEFb. P-TEFb phos-
phorylates the Pol II CTD at Serine 2, which enhances the rate of transcription
elongation.
(C) The Hu family of splicing regulators bind to AU-rich sequences within
introns and repress the splicing of regulated alternative exons. Shown here,
HuR interacts with and represses the activity of the histone deacetylase,
HDAC2, which stabilizes nearby acetylated nucleosomes. Acetylated nucle-
osomes may enhance the rate of transcription elongation, and consequently,
promote the skipping of exons with weak splice sites.required the SNR1/SNF5 subunit, which suppresses BRM
ATPase, and reduced elongation was correlated with more effi-
cient intron splicing (Zraly and Dingwall, 2012).
Covalent modifications of histones impinge on Pol II elonga-
tion in ways that impact AS (Figure 2). The heterochromatinprotein HP1g/CBX3, which binds di- and trimethylated histone
H3K9 (Bannister et al., 2001; Lachner et al., 2001), mediates
inclusion of alternative exons in CD44 transcripts in human cells
upon stimulation of the PKC pathway, concomitantly with an
increase in Pol II occupancy over the alternatively spliced region
(Saint-Andre´ et al., 2011). However, CBX3 may also play a more
direct role in splicing factor recruitment. Depletion of CBX3
in human cells resulted in the accumulation of unspliced
transcripts and loss of recruitment of the U1 snRNP-70 kDa
(SNRNP70) protein and other splicing factors to active chromatin
(Smallwood et al., 2012).
Intriguingly, components of the RNAi machinery in association
with CBX3 were recently shown to also regulate AS of CD44
transcripts. Specifically, the Argonaute proteins AGO1 and
AGO2 were found by ChIP-seq analysis to bind the alternative
exon-containing region of CD44 and were loaded onto this
region by short RNAs derived from CD44 antisense transcripts
(Ameyar-Zazoua et al., 2012). Recruitment of AGO1 and AGO2
to CD44 required Dicer and CBX3 and resulted in increased
histone H3K9 methylation over the variant exons. Recruitment
of AGO proteins to the CD44 gene thus appears to locally induce
a chromatin state that affects Pol II elongation and AS.
RNA-binding proteins bound to nascent RNA may also alter
chromatin composition in ways that impact elongation and
splicing (Figure 3). Hu-family proteins, which have well defined
roles in the control of mRNA stability, were recently shown to
regulate AS by binding to nascent RNA proximal to alternative
exons in a manner that induced local histone hyperacetylation
and increased Pol II elongation (Mukherjee et al., 2011; Zhou
et al., 2011). This activity was linked to the direct inhibition of
histone deacetylase 2 (HDAC2) by Hu proteins (Zhou et al.,
2011).
RNA Pol II elongation rates are also impacted by nucleotide
sequence composition. A/T-rich sequences, in particular, are
more difficult for Pol II to transcribe. A novel complex found to
be associated with human mRNPs, termed DBIRD, facilitates
Pol II elongation across A/T rich sequences (Close et al., 2012).
Depletion of this complex resulted in reduced Pol II elongation
and changes in the splicing of exons proximal to A/T-rich
sequences. It was therefore proposed that DBIRD acts at the
interface of RNA Pol II and mRNP complexes to control AS
(Close et al., 2012).
Finally, the zinc finger DNA-binding transcription factor and
chromatin organizer CTCF has been linked to the regulation of
AS of exon 5 of the receptor-linked protein tyrosine phosphatase
CD45, and of other transcripts, by locally affecting Pol II elonga-
tion (Shukla et al., 2011). Variable inclusion of CD45 exon 5 is
controlled by RNA-binding proteins during peripheral lym-
phocyte maturation (Motta-Mena et al., 2010). Intriguingly,
CTCF appears to maintain the inclusion of exon 5 at the terminal
stages of lymphocyte development by causing Pol II pausing
proximal to this exon (Shukla et al., 2011). CTCF binding is
inhibited by CpG methylation. Accordingly, increased methyla-
tion proximal to CD45 exon 5 led to reduced CTCF occupancy
and reduced exon inclusion (Shukla et al., 2011). Analysis of
AS changes genome-wide using RNA-Seq following depletion
of CTCF further revealed that this factor is likely to have
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elongation kinetics. However, CTCF is known to mediate intra-
chromosomal interactions (Ohlsson et al., 2010), and it therefore
remains to be determined whether the changes in AS caused by
CTCF reflect a direct inhibition of Pol II elongation, or whether
these effects are a consequence of more complex topological
changes to chromatin architecture.
In the examples described above and others (Luco et al.,
2011), changes in AS can be achieved through a variety of
mechanisms that perturb Pol II elongation in a widespread or
locus-specific manner. In other cases, AS is affected through
mechanisms involving the differential recruitment of splicing
factors to transcription or chromatin components. It is currently
unclear to what extent these mechanisms are distinct or overlap
as the recruitment of splicing factors to a transcript in some
cases appears to affect elongation kinetics, and in other cases
altered elongation kinetics may affect the recruitment of splicing
components to chromatin or transcription factors associated
with nascent transcripts. For example, as summarized earlier,
regulation of variable exon inclusion in CD44 transcripts appears
to involve the concerted action of chromatin remodeling, inhibi-
tion of Pol II elongation, and the recruitment of splicing factors
and the RNAi machinery. Individual genes may therefore
possess a unique set of mechanistic principles that are governed
by the specific combinatorial interplay between cis elements of
the splicing code and genomic features, which together deter-
mine the formation and activity of chromatin features and
transcription complexes. The increased use of comparative
analyses of parallel data sets interrogating transcriptomic,
genomic, and chromatin features should nevertheless facilitate
a more detailed mechanistic understanding of common princi-
ples by which chromatin, transcription, and splicing are coupled
to coordinate the regulation of subsets of genes.
Regulation of Chromatin and Transcription
by the Splicing Machinery
In addition to the extensive set of interactions and mechanisms
by which chromatin and transcription components can impact
splicing, increasing evidence indicates that splicing can have
a major impact on chromatin organization and transcriptional
output. Early indications of this ‘‘reverse-coupling’’ were that
the efficient expression of transgene constructs required the
presence of an intron (Brinster et al., 1988). Such effects were
later shown to arise in part as a consequence of enhanced tran-
scription (Furger et al., 2002). Subsequent studies have demon-
strated several mechanisms by which the splicing of nascent
transcripts can impact chromatin organization and transcription.
For example, H3K4me3 and H3K9ac, both of which are associ-
ated with active genes and widely assumed to peak in proximity
to promoters together with increased Pol II occupancy, are in
fact concentrated over first exon-intron boundaries (Bieberstein
et al., 2012) (Figure 3A). In genes with long first exons, these
marks are reduced at promoters, whereas in genes with short
first exons, the marks are increased at promoters as are tran-
scription levels. Confirming a role for first intron splicing in estab-
lishing promoter proximal architecture, intron deletion reduced
H3K4me3 levels and transcriptional output (Bieberstein et al.,
2012). Taken together with previous observations of associa-
tions between U1 and Pol II (Damgaard et al., 2008), and
between U2 snRNP and H3K4me3 (Sims et al., 2007), a picture1260 Cell 152, March 14, 2013 ª2013 Elsevier Inc.emerges in which first intron splicing serves to establish or
perhaps reinforce promoter proximal marks, that in turn recruit
general transcription factors and Pol II to enhance initiation.
The enrichment of H3K36me3 at exons, which is established
by the methyltransferase SETD2 as it travels with elongating
Pol II, also arises in part as a consequence of splicing (Figure 3A).
Global inhibition of splicing (via depletion of specific spliceosome
components and/or exposure to the inhibitor spliceostatin)
decreasedH3K36me3 levels at particular exons, but also broadly
altered its distributionwithin genebodies (deAlmeida et al., 2011;
Kim et al., 2011). To what degree these effects are direct remains
unclear, as global inhibition of splicing would also be expected to
perturb transcription, for example, by affecting the expression
and/or deposition of transcription and chromatin factors (Bieber-
stein et al., 2012). Nonetheless, a direct role also seems likely. For
example, reciprocal H3K79me2 and H3K36me3 histone marks
transition at first intronic 30 splice site-first internal exon bound-
aries, but not at the corresponding boundaries of pseudoexons
(Huff et al., 2010) (ENCODE Project Consortium, 2012), suggests
more direct roles of splicing-dependent transitions in chromatin
modifications (Figure 3A). Moreover, mass spectrometry data
further suggests that SETD2 may associate with exon definition
complexes (Schneider et al., 2010).
Splicing also impacts Pol II pausing and elongation. An asso-
ciation between snRNPs and the Pol II elongation factor TAT-
SF1 can stimulate elongation in vitro, and this activity was further
enhanced by the presence of splicing signals in RNA (Fong and
Zhou, 2001). Because TAT-SF1 interacts with the positive elon-
gation factor P-TEFb, which phosphorylates the S2 residues of
the CTD to increase Pol II processivity, it was proposed that
the assembly of splicing complexes on nascent RNA may facili-
tate Pol II elongation across a gene (Fong and Zhou, 2001).
Additional studies have reported roles for splicing factors in
elongation. Because this topic has been reviewed elsewhere
(Pandit et al., 2008), only a few examples will be highlighted
here. Of particular interest are SR and SR-like proteins, which
have long-established roles in splicing. The S. cerevisiae SR-like
protein Npl3, for example, regulates the splicing of a subset of
introns (Chen et al., 2010; Kress et al., 2008), but it also facilitates
elongation by acting as an antitermination factor (Dermody et al.,
2008). Specific mutations in Npl3 lead to defects in the transcrip-
tion elongation and termination of 30% of genes (Dermody
et al., 2008). Npl3 binds the S2 phosphorylated CTD (Lei et al.,
2001), bringing it into close proximity to nascent RNA. Phosphor-
ylation of Npl3 was found to negatively regulate its binding to the
CTD and RNA, suggesting that unphosphorylated Npl3 specifi-
cally promotes elongation in association with Pol II (Dermody
et al., 2008).
Depletion of the SR family protein SRSF2/SC35 increases
Pol II pausing, most likely as a consequence of defective recruit-
ment of P-TEFb and reduced S2 CTD phosphorylation (Lin et al.,
2008) (Figure 3B). It is interesting to consider that Npl3, SRSF2,
and possibly other RNA-binding proteins, may also facilitate
elongation in part by preventing the formation of DNA-RNA
hybrids (or R-loops) formed by nascent RNA during transcription
(Pandit et al., 2008). Finally, it is also conceivable that SR
proteins bound to nascent RNA indirectly promote CTD phos-
phorylation and/or histone modifications that facilitate
Figure 4. Splicing Impacts the Regulation of Multiple Downstream Steps in Gene Regulation
(A) Coupling connections between splicing and 30-end formation, RNA stability, and mRNA export. Splicing and 30-end formation are coupled by interactions
between exon-bound SR proteins and the cleavage and polyadenylation factor CFIm, and between U2AF and both CFIm and PAP. Cryptic upstream adenylation
sites (PAS) are suppressed by U1 snRNP (left). Splicing impacts RNA stability by interactions between SR proteins and the EJC, which in turn interacts with the
UPF proteins involved in NMD (middle). Splicing influences mRNA export through the splicing-dependent recruitment of the TREX complex, which in turn
interacts with the RNA export factor TAP.
(B) Multitasking roles of RBPs in splicing and alternative polyadenylation, RNA export and RNA transport. Top: the Nova RNA-binding proteins have been shown
to not only regulate alternative splicing, but also alternative polyadenylation (pA). Both of these processes are modulated in a position-dependent manner with
some binding locations promoting splicing and polyadenylation and other locations repressing these processes. The result of this regulation is the generation of
mRNAs with different exons and 30 UTR sequences. Bottom: Similarly, Mbnl RNA-binding proteins impact alternative splicing in a position-dependent manner
and bind to 30 UTRs, where they function to control subcellular mRNA localization.transcription. In this regard, it was recently shown that Npl3
associates in an RNA-independent manner with Bre1, a ubiquitin
ligase with specificity for H2B (Moehle et al., 2012) that facilitates
transcription elongation in vitro (Pavri et al., 2006).
The studies summarized above emphasize important roles for
nascent RNA splicing and the factors that control splicing in
establishing chromatin architecture and in controlling transcrip-
tion. It is interesting to consider, therefore, that a major determi-
nant of gene-specific chromatin architecture emanates from
information provided by cis-acting elements comprising the
splicing code. The previously described case of the Hu family
of hnRNP proteins is illustrative of a mechanism through which
proteins bound to nascent RNA can ‘‘reach back’’ to alter prox-
imal chromatin and affect Pol II elongation (Zhou et al., 2011)
(Figure 3C). Notably, this mode of regulation also mediates
highly ‘‘local’’ changes in chromatin structure that in turn regu-
late the AS regulation of nearby exons. A more systematic inves-
tigation of the roles of splicing components in establishing
region-specific chromatin modifications and functions will beimportant for understanding the crosstalk between chromatin
and splicing.
Integration of Splicing with 30-End Processing,
Turnover, and Transport
Coupling and Coordination of Splicing with 30-End
Formation
Numerous studies have demonstrated communication between
factors involved in the splicing of 30-terminal introns and factors
involved in 30-end cleavage and polyadenylation (CPA), and this
topic has been reviewed in detail elsewhere (Di Giammartino
et al., 2011; Proudfoot, 2011). Similar to the formation of exon-
definition complexes, it has been proposed that U2AF binding
to the 30 splice site of a terminal exon forms interactions with
Cleavage Factor I and the CTD of poly(A) polymerase to mutually
stimulate terminal intron splicing and CPA (Millevoi et al., 2002;
Millevoi et al., 2006) (Figure 4A). SR proteins have also been
implicated in terminal exon crosstalk (Dettwiler et al., 2004;
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binding of CPA factors and splicing factors can result in physio-
logically important changes in AS and transcript levels (Evsyu-
kova et al., 2013) (see below).
In addition to their roles in the control of large networks of
alternative exons, splicing regulators such as Nova and hnRNP
H1 function in the regulation of alternative polyadenylation
(APA) through direct binding to recognition sites clustered
around the CPA signals (Katz et al., 2010; Licatalosi et al.,
2008) (Figure 4B). Although these ‘‘moonlighting’’ roles in APA
regulation appear to be largely independent of the splicing of
proximal exons/introns, regulation of AS and APA by the same
RBPs presumably is important for globally coordinating these
processes in a cell type or condition-dependent manner. For
example, transcript profiling studies have shown that APA is
widespread, affecting at least 50% of transcripts from human
genes (Tian et al., 2005) and that it plays an important role in
controlling the presence of miRNA and RNA-binding protein
target sites in UTR sequences, and therefore mRNA expression
levels (Mayr and Bartel, 2009; Sandberg et al., 2008). Control of
APA and AS by an overlapping set of RBP regulators may
therefore constitute an effective mechanism for functionally
coordinating these steps in RNA processing.
In an analogous manner, U1 snRNP also has dual roles in
splicing and CPA. U1 snRNP is more abundant than other
spliceosomal snRNPs, and this observation hinted that it may
have additional functions in the nucleus. Indeed, recent studies
have shown that, through binding to cryptic 50 splice sites within
pre-mRNAs, U1 snRNP can inhibit premature 30-end formation
at potential CPA sites that are distributed along pre-mRNAs
(Berg et al., 2012) (Figure 4A). In situations where U1 snRNP
becomes limiting, for example during bursts of pre-mRNA
transcription upon activation of neurons or immune cells, where
the ratio of cryptic and bona-fide 50 splice sites may be in excess
of available U1 snRNP, premature CPA sites are activated
leading to transcript shortening (Berg et al., 2012). Furthermore,
reduced U1 snRNP to pre-mRNA ratios resulted in changes in
terminal exon usage, consistent with the mutual stimulation
between the splicing and CPA machineries in terminal exon
definition. The discovery of a role for U1 snRNP in suppressing
CPA has provided further insight into the mechanism by which
certain mutations in 30 UTRs cause disease. For example,
a mutation in the 30 UTR of the p14/ROBLD3 receptor gene
that is causally linked to immunodeficiency creates a 50 splice
site that does not activate splicing but suppresses CPA, leading
to reduced p14/ROBLD3 expression (Langemeier et al., 2012).
Splicing Modulates RNA Stability and Transport
The NMD pathway acts to prevent spurious expression of
incompletely processed or mutant transcripts (Rebbapragada
and Lykke-Andersen, 2009). Although the NMD pathway
appears to be present in some form in all eukaryotes, there are
nonetheless species-specific differences, particularly in the
way PTCs are recognized and in the nature of the degradation
pathways involved. In mammalian cells, PTC recognition relies
to a large extent on deposition of the exon junction complex
(EJC) 20–24 nt upstream of exon-exon junctions. The EJC
encompasses a stable tetrameric core consisting of eIF4AIII,
MAGOH, MLN51, and Y14 proteins, which is deposited on
mRNA during splicing (Tange et al., 2005). This core associates1262 Cell 152, March 14, 2013 ª2013 Elsevier Inc.with a host of SR and SR-related proteins to form megadalton
size complexes that presumably function in mRNP compac-
tion as well as in facilitating coupling of splicing with downstream
steps in gene expression (Singh et al., 2012) (Figures 1 and 4A).
During the pioneer round of translation, EJCs are displaced by
the ribosome (Isken et al., 2008). However, when the ribosome
encounters a PTC more than 50–55 nt upstream of a terminal
exon-exon junction, EJC components associate with upstream
frame shift (UPF) proteins (Figure 4A) that trigger release of the
ribosome through interaction with release factors (eRFs). These
and other interactions ultimately lead to mRNA decay through
pathways that involve 50-end decapping, deadenylation, and
exoribonucleolytic enzymes (Schoenberg and Maquat, 2012).
Alternative splicing coupled to NMD controls the levels
of specific subsets of genes. It has been estimated that approx-
imately 10%–20% of AS events that have the potential to
introduce PTCs lead to substantial changes in overall total
steady-state transcript levels (Pan et al., 2006). In many cases,
these AS-coupled NMD events serve to auto- and cross-
regulate expression levels of regulatory and core factors
involved in splicing and other aspects of RNA metabolism
(Cuccurese et al., 2005; Lareau et al., 2007b; Mitrovich and
Anderson, 2000; Ni et al., 2007; Plocik and Guthrie, 2012;
Saltzman et al., 2008), but important roles in the regulation of
other classes of proteins have also been reported (Barash
et al., 2010; Lareau et al., 2007a).
It is important for a cell to prevent incompletely or aberrantly
processed transcripts from being translated, as such transcripts
may express truncated proteins with aberrant or dominant
negative functions that have harmful consequences. One safe-
guarding mechanism is to prevent release of such transcripts
from the nucleus. The TREX (transcription/export) complex is
a conserved multiprotein complex that links transcription elon-
gation with nuclearmRNA export (Katahira et al., 2009). Although
S. cerevisiae TREX is recruited to intronless transcripts (Stra¨sser
et al., 2002), its mammalian counterpart is incorporated into
maturing mRNPs by the splicing machinery (Masuda et al.,
2005) and further requires binding of the 50 cap by the TREX
component Aly (Cheng et al., 2006). TREX thenmediates associ-
ation with the TAP nuclear export receptor to facilitate mRNA
export through the nuclear pore complex (Stutz et al., 2000;
Zhou et al., 2000) (Figure 4A). Natural intronless genes can
circumvent the necessity for splicing to recruit TREX through
sequence elements that directly mediate TREX- and TAP-
dependent export (Lei et al., 2011). However, transcripts from
some intron-containing yeast genes, for example the gene
encoding the nuclear export factor SUS1, require introns for
efficient nuclear mRNA export (Cuenca-Bono et al., 2011) (see
below).
Regulated intron retention has been harnessed to play impor-
tant regulatory roles in the control of transcript levels. For
example, coordinated regulation of a set of alternative retained
introns controls the expression of the neuron-specific genes
Stx1b, Vamp2, Sv2a, and Kif5a. The splicing regulator Ptbp1,
which is expressed widely in nonneural cells, represses splicing
of these introns, such that the unspliced transcripts are retained
in the nucleus where they are degraded by the exosome
(Yap et al., 2012). Inhibition of Ptbp1 expression by miR-124 in
Figure 5. Organization of the Splicing Components in the Cell Nucleus
Major nuclear domains enriched in splicing and other factors in the mammalian cell nucleus are depicted with known and putative roles indicated. Gray areas
indicate nucleoli.neural cells results in splicing of these introns, allowing export
and translation of the resulting mature mRNAs. With the wealth
of available transcriptome profiling data, it can be expected
that many additional examples of regulated intron removal linked
to functions such as mRNA turnover and transport will soon
emerge.
Although the EJC appears to be seldom required for NMD in
Drosophila, it is important for the localization of developmen-
tally important transcripts. Localization of oskar mRNA to the
posterior pole of the oocyte requires the deposition of the
EJC core components together with an exon-exon junction-
spanning localization element formed by splicing of the first
intron (Ghosh et al., 2012). Changes in alternative splicing,
particularly in UTR regions, have been observed to differen-
tially regulate mRNA localization in mammalian cells (La Via
et al., 2013; Terenzi and Ladd, 2010) and likely represent
a more widely used mode of regulation than currently appreci-
ated. Similar to previously mentioned examples in which
specific RBPs have roles in both AS and APA, specific RBPs
that function in AS regulation can also function in mRNA local-
ization. Transcriptome profiling of cells and tissues deficient of
MBNL1 and MBNL2, coupled with analysis of the in vivo target
sites of these proteins, has revealed that they regulate large
networks of alternative exons involved in differentiation and
development (Charizanis et al., 2012; Wang et al., 2012)
(Figure 4B). A transcriptomic and proteomic analysis of subcel-
lular compartments further uncovered a widespread role for
MBNL proteins in the regulation of transcript localization,
translation, and protein secretion (Wang et al., 2012). These
studies underscore the importance of integrative analyses
that capture information from multiple aspects of mRNA pro-
cessing and expression when analyzing the functions of indi-
vidual RBPs. In particular, it is becoming increasingly evident
that most if not all RBPs in the cell multitask, and the extent
to which the multiple regulatory functions of RBPs arise
through physical (i.e., direct) coupling between processes, as
opposed to independently operating functions, will be
important to determine.Dynamic Nuclear Organization in Splicing Control
The majority of the mechanisms described thus far in this review
invoke the formation and disruption of protein-protein and
protein-RNA interactions in splicing control. However, of critical
importance to any one of these mechanisms in vivo, is the local
availability of active splicing components relative to the re-
quirements for these factors presented by cognate cis-acting
elements in nascent RNA. Regulation of the availability of
splicing components provides a potentially powerful means by
which constitutive and AS events may be controlled. The highly
compartmentalized nature of the cell nucleus, which contains
several different types of nonmembranous substructures, or
‘‘bodies,’’ that concentrate RNA processing factors, provides
such a regulatory architecture. Among the domains that con-
centrate splicing and other RNA processing factors are inter-
chromatin granule clusters or ‘‘speckles,’’ paraspeckles, Cajal
Bodies (CBs) and nuclear stress bodies (Figure 5) (Biamonti
and Vourc’h, 2010; Machyna et al., 2013; Nakagawa and Hirose,
2012; Spector and Lamond, 2011).
Mammalian cell nuclei typically contain 20–50 speckle struc-
tures that concentrate snRNP and non-snRNP splicing factors,
including numerous SR family and SR-like proteins (Spector
and Lamond, 2011). Experiments employing transcriptional
inhibitors and inducible gene loci revealed that splicing factors
can shuttle between speckles and nearby sites of nascent
RNA transcription, and additional studies have shown that
this shuttling behavior can be controlled by specific kinases
and phosphatases that alter the posttranslational modification
status of SR proteins and other splicing factors. These and other
observations led to the proposal that speckles primarily repre-
sent storage sites for splicing factors (Spector and Lamond,
2011). However, more recent studies using antibodies that
specifically recognize the phosphorylated U2 snRNP protein
SF3b155 (P-SF3b155), which is found only in catalytically
activated or active spliceosomes, paint a more complex
picture (Girard et al., 2012). Immunolocalization using an
anti-P-SF3b155 antibody showed spliceosomes localized to
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within—nuclear speckles (Girard et al., 2012). Inhibition of tran-
scription and splicing after SF3b155 phosphorylation further
revealed that posttranscriptional splicing occurs in nuclear
speckles. These results are consistent with results from earlier
studies employing simultaneous fluorescence in situ hybrid-
ization detection of unspliced and spliced transcripts, which
suggested that the introns of specific transcripts are spliced
within speckles (Lawrence et al., 1993).
Paraspeckles are structures that form at the periphery of
speckle domains and have been observed widely across
mammalian cells and tissues (Fox and Lamond, 2010; Naka-
gawa and Hirose, 2012). They have been implicated in the
regulation of gene expression by mediating the nuclear retention
of adenosine-to-inosine (A-to-I) edited transcripts (Fox and
Lamond, 2010). However, the recent discovery that these struc-
tures concentrate on the order of 40multifunctional RNA-binding
proteins suggests yet undiscovered roles in other aspects of
RNA processing (Naganuma et al., 2012).
Mammalian nuclei typically contain several Cajal bodies, and
these domains are thought to represent primary sites of spliceo-
somal and nonspliceosomal snRNP biogenesis, maturation, and
recycling (Machyna et al., 2013). The formation and size of CBs
relates to the transcriptional and metabolic activity of cells, and
these structures are prominent in rapidly proliferating cells.
Because the in vivo concentration of basal spliceosomal compo-
nents, including snRNPs, can impact specific subsets of AS
events (Park et al., 2004), in particular those that are predicted
to regulate levels of RNA processing factors (Saltzman et al.,
2011), it is interesting to consider that processes that control
the formation and activity of CBs could indirectly control AS of
multiple genes to globally coordinate levels of RNA processing
factors according to themetabolic requirements of the cell. Anal-
ogous to this proposed role for CBs, nuclear stress bodies are
structures that form specifically in response to a variety of stress
conditions including heat shock, oxidative stress, or exposure to
toxic materials (Biamonti and Vourc’h, 2010). These structures
are thought to mediate global changes in gene expression, in
part by sequestering splicing factors (Biamonti and Vourc’h,
2010).
An important facet of understanding the role of nuclear
domains in the control of splicing and other steps in gene regu-
lation is to determine how they are formed. Much in the way
nucleoli form around tandem repeats of rRNA genes, formation
of nuclear domains with connections to the splicing process
may be nucleated by—or depend on for integrity—specific
DNA or RNA sequences, including long (intergenic) noncoding
RNAs (lnc/lincRNAs). CBs have been detected at U1 and U2
snRNA gene loci (Smith et al., 1995), although they may
assemble via the association of multiple different protein and
nucleic acid components (Machyna et al., 2013), and stress
body formation is dependent on transcriptionally active, peri-
centric tandem repeats of satellite III sequences bound by heat
shock transcription factor 1 (HSF1) (Biamonti and Vourc’h,
2010).
Speckle domains concentrate MALAT1, a nuclear lncRNA that
appears to participate in controlling the phosphorylation state of
SR proteins (Tripathi et al., 2010). Depletion of human MALAT1
was also reported to alter the nuclear distribution of SRSF11264 Cell 152, March 14, 2013 ª2013 Elsevier Inc.and to lead to changes in SRSF1-dependent AS events (Tripathi
et al., 2010), although a more recent study did not observe such
effects (Zhang et al., 2012). Moreover, recent studies employing
Malat1 knockout mice did not reveal an essential role for this
lncRNA under normal laboratory conditions (Eißmann et al.,
2012; Nakagawa et al., 2012), whereas another study reported
that it is important for metastasis-associated properties of lung
cancer cells (Gutschner et al., 2013). NEAT1, another lncRNA,
is an integral structural component of paraspeckles (Clemson
et al., 2009; Naganuma et al., 2012). A change in the alternative
30-end processing of NEAT1 lncRNA by hnRNP K affects the
formation of these domains (Naganuma et al., 2012). Very
recently, a class of sno-lncRNAs transcribed from a genomic
region linked to Prader-Willi syndrome was shown to sequester
the RBFOX2 splicing regulator and to modulate AS (Yin et al.,
2012). As additional ncRNAs are identified and characterized, it
can be expected that many other examples of ncRNA-based
control of splicing factor availability and functional activity will
be discovered.
In addition to the aforementioned roles for DNA and RNA, it
has recently emerged that the prevalence of low complexity or
disordered protein regions in splicing and other RNA processing
factorsmay play an important role in the formation and regulation
of the activity of nuclear domains. Homotypic and heterotypic
interactions involving these domains and RNA have been shown
to form hydrogel-like structures, and it is intriguing to consider
that such structures act as malleable interfaces or ‘‘matrices’’
with which to dynamically control (i.e., by differential phosphor-
ylation or other posttranslational modifications) the accessibility,
assembly, and activity, of splicing and other highly integrated
regulatory complexes in the cell nucleus (Han et al., 2012;
Kato et al., 2012).
Conclusions and Future Perspectives
During the past several years remarkable strides have been
made in our understanding of how splicing is dynamically
integrated with other layers of gene regulation and within the
context of subnuclear structure and organization. Advance-
ments in high-throughput technologies and computational
approaches, together with focused biochemical, molecular,
and cell biological methods, have powered the discovery and
characterization of the global principles by which splicing forms
a nexus of extensive crosstalk between gene expression
processes. This crosstalk temporally coordinates and enhances,
and in some cases represses, the kinetics of physically coupled
steps in RNA metabolism, but it also serves to coordinately
regulate different steps in the transcription, processing, export,
stability, and translation of mRNA.
Of key importance in future studies will be to determine
the specific conditions and mechanisms by which chromatin-
and transcription-associated components control splicing
outcomes, and vice versa. Current models often propose
networks of physical interactions between these processes.
However, it is unclear to what extent regulatory mechanisms
may rely on increased local concentrations of factors (i.e.,
through associations with chromatin and or other nuclear
domains) that provide kinetic advantages, which in turn promote
‘‘coupled’’ effects. Regardless of the specific mechanisms by
which crosstalk impacts splicing and coupled processes, it is
exciting to consider that entirely new functional connections
await discovery. For example, the role of splicing in the deposi-
tion of specific chromatin marks such as H3K36me3 could
impact additional chromatin mark-regulated functions, such as
DNA replication, repair, andmethylation (Wagner and Carpenter,
2012). The plethora of poorly characterized histone lysine meth-
ylation ‘‘readers’’ such as the tudor, chromodomain, PWWP, and
other ‘‘royal family’’ domain-containing proteins are candidates
for mediating possible new splicing-dependent regulation
involving chromatin marks and their binding to reader proteins
(Yap and Zhou, 2010).
Another important area of future investigation is to establish
the extent to which nucleic-acid-binding proteins multitask to
coordinate different aspects of biology. Although this review
focuses on a few examples of multitasking RBPs, it is telling
that almost every recent study employing in vivo mapping of
binding sites of splicing regulators or other RBPs has uncovered
previously unknown, additional functions of these proteins.
Moreover, other in vivo crosslinking studies using polyadeny-
lated RNA as bait to comprehensively identify RBPs, point to
a much more extensive multitasking world in which transcription
factors and proteins associated with other diverse cellular func-
tions, including metabolism, may have unsuspected functions in
association with RNA (Baltz et al., 2012; Castello et al., 2012). In
this regard, it should be noted that among the largest group of
uncharacterized nucleic-acid-binding factors are C2H2 and
other zinc-finger domain proteins, defined examples of which
can regulate gene expression through binding RNA.
Increasing examples of pivotal roles for switch-like AS events
is providing a perspective in which a relatively small number of
regulated exons can act to rewire entire programs of gene regu-
lation by modifying core domains of proteins that dictate the
activities of regulators of chromatin, transcription, and other
steps in gene regulation (Irimia and Blencowe, 2012). Numerous
other AS events remodel protein interaction and signaling
networks that are important for establishing cell type-specific
functions (Babu et al., 2011; Ellis et al., 2012; Weatheritt and
Gibson, 2012). Such AS events are often found in disordered
domains of proteins that are subject to phosphorylation and
other types of posttranslational modifications. Interestingly,
these domains are often found in splicing factors and other
nuclear gene expression regulators, with the RS-repeat domains
of SR proteins and the CTD of Pol II representing notable exam-
ples. A very important area of future investigation will be to
understand how these and other protein domains contribute to
the assembly and disassembly of higher-order nuclear struc-
tures that function to organize and possibly catalyze splicing
and other nuclear reactions (Han et al., 2012; Kato et al.,
2012). Also central to this understanding will be to discover
and characterize ncRNAs that participate in the dynamic integra-
tion of splicing with other nuclear processes.
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